2021 대한부정맥학회 심방세동 환자의 뇌졸중 예방 관리 지침
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이기홍 | - |
dc.contributor.author | 김진배 | - |
dc.contributor.author | 신승용 | - |
dc.contributor.author | 정보영 | - |
dc.date.accessioned | 2021-11-23T07:40:13Z | - |
dc.date.available | 2021-11-23T07:40:13Z | - |
dc.date.issued | 2021 | - |
dc.identifier.issn | 1738-9364 | - |
dc.identifier.issn | 2289-0769 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/51764 | - |
dc.description.abstract | Atrial fibrillation (AF) is a strong risk factor for ischemic stroke and systemic embolism. To prevent thromboembolic events in patients with AF, anticoagulation therapy is essential. The anticoagulant strategy is determined after stroke and bleeding risk assessments using the CHA2DS2-VASc and HAS-BLED scores, respectively; both consider clinical risk factors. Vitamin K antagonists (VKAs) are the sole anticoagulant option in AF patients with a prosthetic mechanical valve or moderate-severe mitral stenosis; in all other AF patients VKA or non-vitamin K antagonist oral anticoagulants are therapeutic options. However, antiplatelet therapy should not be used for stroke prevention in AF patients. Anticoagulation is not needed in AF patients with low stroke risk but strongly recommended in those with a with low bleeding risk. Left atrial appendage (LAA) occlusion offers an alternative in AF patients in whom long-term anticoagulation is contraindicated. Surgical occlusion or the exclusion of LAA can be considered for stroke prevention in AF patients undergoing cardiac surgery. In this article, we review existing data for stroke prevention and suggest optimal strategies to prevent stroke in AF patients. | - |
dc.format.extent | 16 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한내과학회 | - |
dc.title | 2021 대한부정맥학회 심방세동 환자의 뇌졸중 예방 관리 지침 | - |
dc.title.alternative | 2021 Korean Heart Rhythm Society Guidelines for Stroke Prevention in Atrial Fibrillation | - |
dc.type | Article | - |
dc.identifier.doi | 10.3904/kjm.2021.96.4.296 | - |
dc.identifier.bibliographicCitation | 대한내과학회지, v.96, no.4, pp 296 - 311 | - |
dc.identifier.kciid | ART002774650 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | 311 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 296 | - |
dc.citation.title | 대한내과학회지 | - |
dc.citation.volume | 96 | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Atrial fibrillation | - |
dc.subject.keywordAuthor | Stroke | - |
dc.subject.keywordAuthor | Hemorrhage | - |
dc.subject.keywordAuthor | Thrombosis | - |
dc.subject.keywordAuthor | Embolism | - |
dc.description.journalRegisteredClass | kciCandi | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.